Elite Pharmaceuticals, Inc. (OTCMKTS:ELTP – Get Free Report)’s stock price crossed above its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $0.55 and traded as high as $0.57. Elite Pharmaceuticals shares last traded at $0.57, with a volume of 916,561 shares.
Elite Pharmaceuticals Stock Up 3.3 %
The company has a current ratio of 3.52, a quick ratio of 2.42 and a debt-to-equity ratio of 0.10. The company has a market capitalization of $608.92 million, a P/E ratio of -57.00 and a beta of 0.25. The firm’s 50 day moving average price is $0.55 and its two-hundred day moving average price is $0.35.
Elite Pharmaceuticals Company Profile
Elite Pharmaceuticals, Inc, a specialty pharmaceutical company, engages in the development, manufacture, and sale of oral, controlled-release products, and generic pharmaceuticals. The company operates in two segments, Abbreviated New Drug Applications for Generic Pharmaceuticals and New Drug Applications for Branded Pharmaceuticals.
Read More
- Five stocks we like better than Elite Pharmaceuticals
- How to Calculate Inflation Rate
- Micron Stock Under $100: Seize the AI-Driven Upside
- What does consumer price index measure?
- AI’s Next Big Winners: 3 Small-Cap Stocks to Watch in 2025
- What Investors Need to Know to Beat the Market
- SolarEdge Stock Climbs Back: Goldman Sachs Sees 40% Upside
Receive News & Ratings for Elite Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elite Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
